Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian CancerShannon N. Westin, Gordon B. Mills, Jennifer K. Litton et al.|Clinical Cancer Research|2021Cited by 76